114 related articles for article (PubMed ID: 31841793)
21. Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial.
Potter AL; Costantino CL; Suliman RA; Haridas CS; Senthil P; Kumar A; Mayne NR; Panda N; Martin LW; Yang CJ
Ann Thorac Surg; 2023 Oct; 116(4):684-692. PubMed ID: 37356517
[TBL] [Abstract][Full Text] [Related]
22. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
Varlotto JM; Yao AN; DeCamp MM; Ramakrishna S; Recht A; Flickinger J; Andrei A; Reed MF; Toth JW; Fizgerald TJ; Higgins K; Zheng X; Shelkey J; Medford-Davis LN; Belani C; Kelsey CR
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):765-73. PubMed ID: 25752390
[TBL] [Abstract][Full Text] [Related]
23. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
[No Abstract] [Full Text] [Related]
24. Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.
Voynov G; Heron DE; Lin CJ; Burton S; Chen A; Quinn A; Santos R; Colonias A; Landreneau RJ
Brachytherapy; 2005; 4(4):278-85. PubMed ID: 16344258
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study.
Chouaid C; Danson S; Andreas S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Price M; Chirila C; Hollis K; Sweeney C; Wolowacz S; Kaye JA; Kontoudis I
Lung Cancer; 2018 Oct; 124():310-316. PubMed ID: 30119925
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial.
Trodella L; Granone P; Valente S; Valentini V; Balducci M; Mantini G; Turriziani A; Margaritora S; Cesario A; Ramella S; Corbo GM; D'Angelillo RM; Fontana A; Galetta D; Cellini N
Radiother Oncol; 2002 Jan; 62(1):11-9. PubMed ID: 11830308
[TBL] [Abstract][Full Text] [Related]
27. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
[TBL] [Abstract][Full Text] [Related]
28. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.
Schuchert MJ; Pettiford BL; Keeley S; D'Amato TA; Kilic A; Close J; Pennathur A; Santos R; Fernando HC; Landreneau JR; Luketich JD; Landreneau RJ
Ann Thorac Surg; 2007 Sep; 84(3):926-32; discussion 932-3. PubMed ID: 17720401
[TBL] [Abstract][Full Text] [Related]
29. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinoma.
Ratto GB; Zino P; Mirabelli S; Minuti P; Aquilina R; Fantino G; Spessa E; Ponte M; Bruzzi P; Melioli G
Cancer; 1996 Jul; 78(2):244-51. PubMed ID: 8673999
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
32. Postoperative radiotherapy in radically resected non-small cell lung cancer.
Mayer R; Smolle-Juettner FM; Szolar D; Stuecklschweiger GF; Quehenberger F; Friehs G; Hackl A
Chest; 1997 Oct; 112(4):954-9. PubMed ID: 9377958
[TBL] [Abstract][Full Text] [Related]
33. Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: an early closed randomized controlled trial.
Shen WY; Ji J; Zuo YS; Pu J; Xu YM; Zong CD; Tao GZ; Chen XF; Ji FZ; Zhou XL; Han JH; Wang CS; Yi JG; Su XL; Zhu WG
Radiother Oncol; 2014 Jan; 110(1):120-5. PubMed ID: 24183868
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
[TBL] [Abstract][Full Text] [Related]
35. Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer.
Baine MJ; Verma V; Schonewolf CA; Lin C; Simone CB
Lung Cancer; 2018 Apr; 118():20-26. PubMed ID: 29571997
[TBL] [Abstract][Full Text] [Related]
36. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
[TBL] [Abstract][Full Text] [Related]
37. Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy.
Little AG; DeMeester TR; Ferguson MK; Skinner DB; Hoffman PC; Skosey C; Blough RR; Golomb HM
Surgery; 1986 Oct; 100(4):621-8. PubMed ID: 3020725
[TBL] [Abstract][Full Text] [Related]
38. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
[TBL] [Abstract][Full Text] [Related]
39. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
40. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
Albain KS; Rusch VW; Crowley JJ; Rice TW; Turrisi AT; Weick JK; Lonchyna VA; Presant CA; McKenna RJ; Gandara DR
J Clin Oncol; 1995 Aug; 13(8):1880-92. PubMed ID: 7636530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]